Tailored Exercise Training Study Among Adults With HFpEF

Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Texas Southwestern Medical Center

About this trial

Heart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercise intolerance (EI) is the cardinal symptom of HFpEF, which manifests as dyspnea and fatigue. EI leads to functional deconditioning and reduced quality of life (QOL), both of which elevate risk of death and hospitalization in patients with HFpEF. Supervised exercised training is associated with improvements in exercise capacity and QOL in adults with HFpEF. However, supervised exercise has not been widely utilized for the treatment of HFpEF due to logistical and fiscal barriers.

This study will investigate the effects of a remote exercise training intervention on exercise capacity and skeletal muscle composition in patients with HFpEF, or those at risk for it. In addition, it will compare four different lifestyle interventions for their effects on exercise capacity.

Eligibility criteria

Qualifiers

Age>= 18 yrs

LVEF (Left Ventricular Ejection Fraction) >= 50%

History of HFpEF or at risk of HFpEF

HFpEF diagnosis based on:- -HF hospitalization within 12 months-

Disqualifiers

Hospitalization 1 month prior to baseline visit

History of recurrent falls

eGFR (Estimated Glomerular Filtration Rate) <20ml/min/1.73m

Active changes in HF therapies over 2 weeks prior to baseline visit

Trial design

Treatments tested in this trial

  • Moderate-intensity continuous training (MCT)
  • Resistance training
  • Weight loss

Treatment groups

120 Participants
are divided into 4 treatment groups